WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Stock Jumps 13.5% – Time to Buy?

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY)’s stock price rose 13.5% on Thursday. The company traded as high as $12.60 and last traded at $12.48. 1,737 shares were traded during mid-day trading, a decline of 98% from the average session volume of 70,057 shares. The stock had previously closed at $11.00.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of WuXi Biologics (Cayman) to a “hold” rating in a research report on Friday, August 28th. One equities research analyst has rated the stock with a Hold rating. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold”.

WuXi Biologics (Cayman) Stock Performance

The company has a 50-day moving average of $12.81 and a 200-day moving average of $10.23.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Inc is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company works with pharmaceutical and biotechnology companies to support the discovery, development and commercial manufacturing of therapies, helping customers advance drug candidates from early research through clinical and commercial production.

Its capabilities include antibody and recombinant protein development, cell-line development, process development, clinical trial material production and large-scale biomanufacturing.